AstraZeneca is a global, science-led biopharmaceutical company, based in Cambridge, UK. Since entering China in 1993, AstraZeneca has focused on the utmost needs of Chinese patients covering therapy areas of oncology, cardiovascular, renal, metabolism, respiratory, gastrointestinal, rare diseases, vaccine and antibody and immunology, bringing over 40 global innovative medicines to China. AstraZeneca has established its China headquarters in Shanghai, with two global strategic R&D centers located in Shanghai and Beijing. We have also established regional headquarters in Beijing, Guangzhou, Hangzhou, Chengdu and Qingdao. Our global manufacturing sites in Wuxi, Taizhou, and Qingdao are providing high quality medicines to over 70 global markets.